Downloadable Slidesets

Share

Program Content

Activities

  • Biomarkers in HER2-Negative EBC
    Overview of Risk Assessment and Biomarker Testing to Inform Treatment in HER2-Negative Early Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 06, 2022

    Expires: April 05, 2023

  • Adj Abemaciclib HR+/HER2- EBC
    Risk Assessment and Ki-67 Testing in HR-Positive/HER2-Negative EBC for Adjuvant Abemaciclib
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 12, 2022

    Expires: May 11, 2023

  • Adjuvant Olaparib HER2- EBC
    Germline BRCA Testing and Targeting With Adjuvant Olaparib in HER2- EBC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 17, 2022

    Expires: May 16, 2023

  • ICI in Early TNBC
    Immune Checkpoint Inhibition in Early-Stage TNBC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 15, 2022

    Expires: September 14, 2023

  • Key Trials in HR+/HER2- EBC
    Key Ongoing Clinical Trials in HR-Positive/HER2-Negative Early-Stage Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 22, 2022

    Expires: September 21, 2023

Provided by

ProCE Banner

Supporters

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Partners

Smart Patients

ProCE Banner